ABL
Mathilde Arnault is currently working as an Analytical Specialist at ABL Europe, a CDMO specializing in GMP manufacturing and development of viral vectors. Prior to this role, Mathilde worked at Merck Life Science where Mathilde held positions as a Technical Leader in BioMonitoring R&D, and as a Research Scientist in the same department. Mathilde also completed an internship as a Research Scientist in Infectious disease R&D at Sanofi. Additionally, Mathilde was part of the International Genetically Engineered Machine (IGEM) competition in 2010 as an active member of the team from INSA Lyon, earning a silver medal. Mathilde holds an Engineer's degree in Biotechnology and Biochemistry from INSA Lyon and KTH Royal Institute of Technology.
This person is not in any offices
ABL
From development to market ABL Europe provides GMP viral vectors, contributing to the success of our clients’ immunotherapy innovations. ABL Europe SAS is a pure-play GMP CMO licensed in accordance with EMA, completely dedicated to the provision of viral vector GMP contract manufacturing services, and a subsidiary of ABL Inc. under the corporate ownership of Institut Mérieux. ABL has a strong technical & regulatory track record in process development, scale-up & GMP manufacturing of filterable & non-sterile filterable (aseptic processing) viral vectors used in all phases of clinical development globally. With different adherent platforms (< 60 m2) and suspension (< 500 L) capabilities for drug substance and drug product (< 10,000 vials per batch) in-house, experience in process characterisation and validation, ABL provides its clients with a long-term strategic manufacturing option through clinical development & licensure for a range of virus vector gene therapy & vaccine products. ABL Europe’s clients are located worldwide.